QQ客服 官方微博 反馈留言

浏览/检索结果: 共14条，第1-10条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy or non-small cell lung cancer 期刊论文 2019, 卷号: 11, 期号: 5, 页码: 1779-+ 作者:  Liu, Yu-Tao;  Han, Xiao-Hong;  Xing, Pu-Yuan;  Hu, King-Sheng;  Hao, Xue-Zhi 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Non-small cell lung cancer (NSCLC)  circular RNA (circRNA)  epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)  predictive biomarker   Re-biopsy status among Chinese non-small-cell lung cancer patients who progressed after icotinib therapy 期刊论文 2018, 卷号: 11, 页码: 7513-7519 作者:  Wang, Hanping;  Zhang, Li;  Si, Xiaoyan;  Zhang, Xiaotong;  Wang, Mengzhao 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 re-biopsy  T790M mutation  resistant mechanism  EGFR-TKI  icotinib  non-small-cell lung cancer   Upfront Radiation Therapy with TKI Improved the Intracranial PFS but Not OS in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases 期刊论文 2018, 卷号: 102, 期号: 3, 页码: S232-S232 作者:  Wang, C.;  Lu, X.;  Zhou, Z.;  Bi, N.;  Wang, J. 收藏  |  浏览/下载：12/0  |  提交时间：2020/01/03 Targeted drugs for systemic therapy of lung cancer with brain metastases 期刊论文 2018, 卷号: 9, 期号: 4, 页码: 5459-5472 作者:  Sun, Ya-Wen;  Xu, Jian;  Zhou, Jun;  Liu, Wen-Juan 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03 brain metastases  lung cancer  target drug  EGFR-TKI  ALK   A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy 期刊论文 2018, 卷号: 24, 期号: 15, 页码: 3583-3592 作者:  Song, Jiangdian;  Shi, Jingyun;  Dong, Di;  Fang, Mengjie;  Zhong, Wenzhao 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Upfront Radiation Therapy with TKI Improved the Intracranial PFS but Not OS in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases 会议论文 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018-11-01 作者:  Wang, C.;  Lu, X.;  Zhou, Z.;  Bi, N.;  Wang, J. 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Postoperative survival of EGFR-TKI-targeted therapy in non-small cell lung cancer patients with EGFR 19 or 21 mutations: a retrospective study 期刊论文 2017, 卷号: 15, 期号: 1, 页码: 197 作者:  Yang, Wenjing;  Gao, Yibo;  Li, Xuelian;  Zhang, Jing;  Liu, Tiejun 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Non-small cell lung cancer  EGFR mutation subtypes  Targeted therapy  Postoperative survival   Open label, multi-center, prospective study to investigate the efficacy and safety of osimertinib in brain metastases from patients with EGFR T790M positive NSCLC who have received prior therapy with an EGFR-TKI (APOLLO Study, NCT02972333) 会议论文 ANNALS OF ONCOLOGY, 2017-04-01 作者:  Wang, L.;  Xing, L.;  Cao, L.;  Wang, X.;  Feng, J. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Open label, multi-center, prospective study to investigate the efficacy and safety of osimertinib in brain metastases from patients with EGFR T790M positive NSCLC who have received prior therapy with an EGFR-TKI (APOLLO Study, NCT02972333) 期刊论文 2017, 卷号: 28 作者:  Wang, L.;  Xing, L.;  Cao, L.;  Wang, X.;  Feng, J. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution (Review) 期刊论文 2017, 卷号: 37, 期号: 3, 页码: 1347-1358 作者:  Li, Kaidi;  Yang, Maojun;  Liang, Naixin;  Li, Shanqing 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 epidermal growth factor receptor  non-small cell lung cancer  uncommon mutations  G719X mutation  tyrosine kinase inhibitor  tyrosine kinase inhibitor sensitivity  targeted therapy  methodology